Psychopharmacology Maastricht
The psychopharmacology department at Maastricht University focuses on the cognitive, behavioral, and biological effects of various substances, ranging from pharmaceutical to recreational drugs.
Learn More
NEW paper out by Eline Haijen on trait mindfulness and personality characteristics in a microdosing ADHD
Read about our new microdosing for ADHD study!
Congratulations to Eline Haijen on her newly published study on mindfulness and personality characteristics in a microdosing ADHD sample
Read The PaperParticipate in our studies!
We're always conducting research in our department and we're frequently looking for participants to be a part of science! If you're interested, look at the studies that we are currently conductings.
View All Studies
Meet our Department!
The scientists in our lab come from many countries and backgrounds, all with highly unique research abilities. Come meet the people that make up the Psychopharmacology Department.
Learn MoreOur Scientists
Dr. Lilian Kloft
False Memory, Drugs, Cognition
I am a postdoctoral researcher in the fields of psychopharmacology and forensic psychology with an international education from various high-class universities.
Dr. Eef Theunissen
Synthetic Cannabinoids, Drugs and Driving, Cognition
I began my Ph.D. journey in 2001 at the Faculty of Psychology at the University of Maastricht. My research focused on investigating the sedating and stimulating effects of antihistamines, with a particular emphasis on their...
Dr. Kim Kuypers
Microdosing, Cognition, Nutrition
My research focuses on the neurobiology of flexible cognition, empathy, and well-being.
Dr. Frederick Vinckenbosch
I am a researcher investigating various topics concerning the effects of psychoactive substances, both licit and illicit, on driving performance.
Dr. Natasha Mason
Psychedelics, Neuroadaptations, Plasticity
My research is driven by my desire to find effective treatments for psychiatric disorders, particularly anxiety, depression, and post-traumatic stress disorder.
Johannes Reckweg, MSc
5-MeO-DMT, Neuropsychopharmacology, Therapy
I am Johannes, a PhD candidate from Germany. After receiving my Bachelor’s degree from the Rijksuniversiteit Groningen, I came to Maastricht for my Master in Neuropsychology.
Dr. Rudy Schreiber
CNS Drug Discovery, Research Domain Criteria
I started my career in central nervous system drug discovery in 1993 and subsequently progressed from bench scientist to senior leadership roles at global pharmaceutical companies
Mauro Cavarra, MSc
Psychosomatics, Chronic Pain, Psychedelic-Assisted Psychotherapy
I am a psychotherapist, hypnotherapist and clinical trainer interested in understanding the connection between mind and body. At the Department I work in research projects that explore the potential of psychedelic therapies in the treatment...
Dr. Pim Heckman
Dopamine, Nucleotide Signaling, Sleep
My academic training and research experience have provided me with an excellent background in multiple psychological disciplines including neurobiology, neuropsychology, and neuropsychopharmacology.
Psychedelic Research
Trait mindfulness and personality characteristics in a microdosing ADHD sample: a naturalistic prospective survey study
→
Ritualistic use of ayahuasca enhances a shared functional connectome identity with others
Functional Connectivity, Ayahuasca, Ritual
→
Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin
→
The use patterns of novel psychedelics: experiential fingerprints of substituted phenethylamines, tryptamines and lysergamides
→
Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study
→
Cannabis Research
Intoxication by a synthetic cannabinoid (JWH-018) causes cognitive and psychomotor impairment in recreational cannabis users
Cognition, Psychomotor, Cannabis
→
Cannabis induced increase in striatal glutamate associated with loss of functional corticostriatal connectivity
Glutamate, Functional Connectivity, Cannabis
→
Cognition and motor control as a function of 9-THC concentration in serum and oral fluid: Limits of impairment
→
Comparison of Cannabinoid Pharmacokinetic Properties in Occasional and Heavy Users Smoking a Marijuana or Placebo Joint
→
Get in Touch
We are always up for communicating with people that have interesting ideas or questions. If you want to contact our department, please reach out using this form below.